{"id":3982,"date":"2024-05-07T10:44:21","date_gmt":"2024-05-07T02:44:21","guid":{"rendered":"https:\/\/flcube.com\/?p=3982"},"modified":"2024-10-23T17:55:49","modified_gmt":"2024-10-23T09:55:49","slug":"pfizer-appoints-citigroups-andrew-baum-as-executive-vice-president-for-strategy-and-innovation","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=3982","title":{"rendered":"Pfizer Appoints Citigroup&#8217;s Andrew Baum as Executive Vice-President for Strategy and Innovation"},"content":{"rendered":"\n<p>Pfizer Inc. (<a href=\"https:\/\/www.google.com\/finance\/quote\/PFE:NYSE\">NYSE: PFE<\/a>) has announced the appointment of Andrew Baum, M.D., to serve as Chief Strategy and Innovation Officer and Executive Vice-President. Baum, who will report directly to Pfizer&#8217;s Chairman and CEO Dr. Albert Bourla, brings a wealth of financial experience to the role, despite having no prior experience in the pharmaceutical industry. Most recently, Baum was head of global healthcare and managing director of equity research at Citigroup, where he has been since 2011. Prior to his tenure at Citigroup, Baum was responsible for European Pharmaceuticals coverage at Morgan Stanley for 14 years. He began his career as a practicing physician at the Royal National Orthopaedic Hospital in Oxford, UK.<\/p>\n\n\n\n<p>Baum is already familiar to Pfizer&#8217;s leadership, having frequently engaged with the company&#8217;s executives as an analyst and providing an investor&#8217;s perspective during earnings calls. In his new role, Baum will leverage his expertise in portfolio analysis, prioritizing products, business development, strengthening biotech partnerships, and commercial evaluation of Pfizer&#8217;s pipeline R&amp;D activities. He will also chair Pfizer&#8217;s Portfolio Management Team, overseeing portfolio management and capital deployment across the company&#8217;s R&amp;D pipeline.<\/p>\n\n\n\n<p>Baum is set to assume his new role at Pfizer from June 3, 2024. He succeeds Aamir Malik, who transitions into a new role as Chief US Commercial Officer at Pfizer.<\/p>\n\n\n\n<p>Pfizer&#8217;s appointment of Baum follows a trend in the industry, similar to Sanofi&#8217;s appointment of Houman Ashrafian, formerly of SV Health Investors, to lead its global R&amp;D last year. Ashrafian, who also began his career as a physician at Oxford&#8217;s Radcliffe Hospital, has a background in founding several biotech companies.- <a href=\"https:\/\/flcube.com\">Flcube.com<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Inc. (NYSE: PFE) has announced the appointment of Andrew Baum, M.D., to serve as&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[863,309],"class_list":["post-3982","post","type-post","status-publish","format-standard","hentry","category-company","tag-nyse-pfe","tag-pfizer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pfizer Appoints Citigroup&#039;s Andrew Baum as Executive Vice-President for Strategy and Innovation - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Pfizer Inc. (NYSE: PFE) has announced the appointment of Andrew Baum, M.D., to serve as Chief Strategy and Innovation Officer and Executive Vice-President. Baum, who will report directly to Pfizer&#039;s Chairman and CEO Dr. Albert Bourla, brings a wealth of financial experience to the role, despite having no prior experience in the pharmaceutical industry. Most recently, Baum was head of global healthcare and managing director of equity research at Citigroup, where he has been since 2011. Prior to his tenure at Citigroup, Baum was responsible for European Pharmaceuticals coverage at Morgan Stanley for 14 years. He began his career as a practicing physician at the Royal National Orthopaedic Hospital in Oxford, UK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=3982\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Appoints Citigroup&#039;s Andrew Baum as Executive Vice-President for Strategy and Innovation\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=3982\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-07T02:44:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-23T09:55:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=3982#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=3982\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Pfizer Appoints Citigroup&#8217;s Andrew Baum as Executive Vice-President for Strategy and Innovation\",\"datePublished\":\"2024-05-07T02:44:21+00:00\",\"dateModified\":\"2024-10-23T09:55:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=3982\"},\"wordCount\":293,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NYSE: PFE\",\"Pfizer\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=3982#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=3982\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=3982\",\"name\":\"Pfizer Appoints Citigroup's Andrew Baum as Executive Vice-President for Strategy and Innovation - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2024-05-07T02:44:21+00:00\",\"dateModified\":\"2024-10-23T09:55:49+00:00\",\"description\":\"Pfizer Inc. (NYSE: PFE) has announced the appointment of Andrew Baum, M.D., to serve as Chief Strategy and Innovation Officer and Executive Vice-President. Baum, who will report directly to Pfizer's Chairman and CEO Dr. Albert Bourla, brings a wealth of financial experience to the role, despite having no prior experience in the pharmaceutical industry. Most recently, Baum was head of global healthcare and managing director of equity research at Citigroup, where he has been since 2011. Prior to his tenure at Citigroup, Baum was responsible for European Pharmaceuticals coverage at Morgan Stanley for 14 years. He began his career as a practicing physician at the Royal National Orthopaedic Hospital in Oxford, UK.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=3982#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=3982\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=3982#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Appoints Citigroup&#8217;s Andrew Baum as Executive Vice-President for Strategy and Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pfizer Appoints Citigroup's Andrew Baum as Executive Vice-President for Strategy and Innovation - Insight, China&#039;s Pharmaceutical Industry","description":"Pfizer Inc. (NYSE: PFE) has announced the appointment of Andrew Baum, M.D., to serve as Chief Strategy and Innovation Officer and Executive Vice-President. Baum, who will report directly to Pfizer's Chairman and CEO Dr. Albert Bourla, brings a wealth of financial experience to the role, despite having no prior experience in the pharmaceutical industry. Most recently, Baum was head of global healthcare and managing director of equity research at Citigroup, where he has been since 2011. Prior to his tenure at Citigroup, Baum was responsible for European Pharmaceuticals coverage at Morgan Stanley for 14 years. He began his career as a practicing physician at the Royal National Orthopaedic Hospital in Oxford, UK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=3982","og_locale":"en_US","og_type":"article","og_title":"Pfizer Appoints Citigroup's Andrew Baum as Executive Vice-President for Strategy and Innovation","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=3982","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-05-07T02:44:21+00:00","article_modified_time":"2024-10-23T09:55:49+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=3982#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=3982"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Pfizer Appoints Citigroup&#8217;s Andrew Baum as Executive Vice-President for Strategy and Innovation","datePublished":"2024-05-07T02:44:21+00:00","dateModified":"2024-10-23T09:55:49+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=3982"},"wordCount":293,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NYSE: PFE","Pfizer"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=3982#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=3982","url":"https:\/\/flcube.com\/?p=3982","name":"Pfizer Appoints Citigroup's Andrew Baum as Executive Vice-President for Strategy and Innovation - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2024-05-07T02:44:21+00:00","dateModified":"2024-10-23T09:55:49+00:00","description":"Pfizer Inc. (NYSE: PFE) has announced the appointment of Andrew Baum, M.D., to serve as Chief Strategy and Innovation Officer and Executive Vice-President. Baum, who will report directly to Pfizer's Chairman and CEO Dr. Albert Bourla, brings a wealth of financial experience to the role, despite having no prior experience in the pharmaceutical industry. Most recently, Baum was head of global healthcare and managing director of equity research at Citigroup, where he has been since 2011. Prior to his tenure at Citigroup, Baum was responsible for European Pharmaceuticals coverage at Morgan Stanley for 14 years. He began his career as a practicing physician at the Royal National Orthopaedic Hospital in Oxford, UK.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=3982#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=3982"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=3982#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Pfizer Appoints Citigroup&#8217;s Andrew Baum as Executive Vice-President for Strategy and Innovation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/3982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3982"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/3982\/revisions"}],"predecessor-version":[{"id":9026,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/3982\/revisions\/9026"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}